The role of high-flow nasal therapy in bronchiectasis: a <i>post hoc</i> analysis.

Show simple item record Good, William R Garrett, Jeffrey Hockey, Hans UP Jayaram, Lata Wong, Conroy Rea, Harold
dc.coverage.spatial England 2021-03-16T01:14:08Z 2021-03-16T01:14:08Z 2021-1
dc.identifier.citation ERJ open research 7(1) Jan 2021
dc.identifier.issn 2312-0541
dc.description.abstract <b>High-flow nasal therapy significantly reduces exacerbation rates and improves quality of life in patients with stable bronchiectasis. High-flow nasal therapy is therefore a potential treatment option for patients with bronchiectasis.</b>
dc.format.medium Electronic-eCollection
dc.language eng
dc.publisher European Respiratory Society (ERS)
dc.relation.ispartofseries ERJ open research
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.
dc.title The role of high-flow nasal therapy in bronchiectasis: a <i>post hoc</i> analysis.
dc.type Journal Article
dc.identifier.doi 10.1183/23120541.00711-2020
pubs.issue 1
pubs.begin-page 00711
pubs.volume 7 2021-02-19T08:15:37Z
dc.rights.holder Copyright: ERS en
pubs.end-page 02020
pubs.publication-status Published
dc.rights.accessrights en
pubs.subtype letter
pubs.subtype Journal Article
pubs.elements-id 838730
dc.identifier.eissn 2312-0541
dc.identifier.pii 00711-2020 2020-12-10

Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record


Search ResearchSpace